SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-14-005328
Filing Date
2014-11-06
Accepted
2014-11-06 16:01:04
Documents
2
Period of Report
2014-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FILING DOCUMENT document.htm 8-K 8798
2 PRESS RELEASE newsrelease.htm EX-99 100281
  Complete submission text file 0001171843-14-005328.txt   110393
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 650-745-7802
HYPERION THERAPEUTICS INC (Filer) CIK: 0001386858 (see all company filings)

IRS No.: 611512713 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35614 | Film No.: 141200553
SIC: 2834 Pharmaceutical Preparations